Allurion
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
11 Huron Natick Massachusetts 01760, Nat...Phone Number
(508) 647-4000Website
www.allurion.comRevenue
$17.2 MillionStock Symbol
ALURIndustry
About Allurion
Allurion Org Chart
Is Allurion your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Allurion
Allurion, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Allurion has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Allurion launches new products
Click to see if Allurion had a recent Job posting/layoffs
Check if Allurion has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Allurion recently announced quarterly report
Check out if Allurion is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Allurion
Compare insights from companies similar to Allurion, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Allurion is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Allurion is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Allurion.
Allurion financials insights
Gather financial insights about Allurion, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Private Equity
$6M
Multiple Rounds
$52M
Series B
$34M
Debt
$1M
Debt
$1M
Debt
$25M
Stock Offering
$100M
Debt
$48M
Share Placement
$2.3M
Stock/Share Issuance
$5M
Allurion Tech Stack
A closer look at the technologies used by Allurion
Most Recent Scoops
Allurion News & Media
Allurion Passes Critical FDA Milestones, Enters Into Transaction to Exchange All ... - Yahoo Finance
NATICK, Mass., November 11, 2025--Allurion Technologies, Inc. (NYSE: ALUR) ("Allurion" or the "Company"), a pioneer in metabolically healthy weight loss, today announced it has passed critical milestones in the U.S. Food and Drug Administration (the "FDA") Pre-Market Approval ("PMA") process for the Allurion Smart Capsule.Allurion Announces Strategic Distribution Partnership with Minogue Medical in Canada to Pioneer New Approach Focused on Metabolically Healthy Weight Loss
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR--Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced a strategic distribution partnership with Minogue Medical Inc., a leading Canadian medical device company specializing in bariatric and obesity care. This new partnership draws upon Minogue Medical’s 40-year experience in the Canadian market and reflects Allurion’s commitment to establishing a new standard of care in obesity management focused on metAllurion Announces Submission of PMA to FDA and Additional Analyses From Pivotal AUDACITY Study That Meet Both Endpoints
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR--Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced submission of the fourth and final module of the Pre-Market Approval (PMA) application to the Food & Drug Administration (FDA) and additional, supportive analyses from the AUDACITY Study that meet both of the pre-specified co-primary endpoints. Topline results announced previously showed that the AUDACITY Study met its first co-primary endpoint relatAllurion Announces Findings from New Studies on Muscle Mass Maintenance in Nearly 20,000 Patients and Four-Year Weight Loss Outcomes at the 2025 Annual Meeting of the ASMBS
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR--Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today presented two new abstracts at the American Society for Metabolic & Bariatric Surgery (ASMBS) 2025 Annual Meeting. This data include findings from a global, real-world experience evaluating body composition outcomes that demonstrate sustained weight loss, significant fat loss, and preservation of muscle mass with the Allurion Program and one of the longest rea
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Allurion
Allurion is a pioneer in metabolically healthy weight loss. The Allurion Program is a weight-loss platform that combines the Allurion Smart Capsule, the worlds first and only swallowable, ProcedurelessTM gastric balloon for weight loss, the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for health... Read More

